Live MD Anderson Cancer Center News with Latest Updates

Live MD Anderson Cancer Center news and developments with the latest updates. Check out current MD Anderson Cancer Center news stories and find out what happened, what is going on with MD Anderson Cancer Center. Recent news updates about MD Anderson Cancer Center
Osteosarcoma profiling reveals why immunotherapy remains ineffective
MD Anderson announces strategic collaboration with Denali Therapeutics to research and develop targeted therapies for neurodegenerative diseases
MD Anderson receives more than $20 million in CPRIT funding
Houston Dash join Dynamo, MD Anderson in Making Cancer History
Absent p53, oral cancers recruit and reprogram nerves to fuel tumor growth
CD19 CAR NK-cell therapy achieves 73% response rate in patients with leukemia and lymphoma
Study provides new understanding of mitochondria genome with potential for new avenues of treatment for multiple cancers
Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment
Lung cancer screening decision aid delivered through tobacco quitlines improves informed decision-making
Researchers identify immune-suppressing target in glioblastoma
Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival
CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
Combination therapy more effective than chemotherapy alone for many newly diagnosed leukemia patients
MD Anderson-convened consortium provides first universal recommendations for pediatric patients with sinusoidal obstructive syndrome
Acupuncture reduces radiation-induced dry mouth for cancer patients
San Antonio luncheon to honor former U.S. Sec. of State Rex Tillerson
MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
MD Anderson and Takeda Announce Collaboration to Accelerate Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
MD Anderson and Varian partner to optimize radiation oncology treatment
MD Anderson expanding its presence in Woodlands
Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations
PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients
Study shows nearly half of cancer patients who enter a comprehensive tobacco treatment program quit smoking
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
In Memory of T. Boone Pickens
MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
MD Anderson receives more than $19 million in CPRIT funding
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Bacteria on tumors influences immune response and survival of patients with pancreatic cancer
MD Anderson to expand Proton Therapy Center